For acamprosate, variables related to abstinence and detoxification before the trial also were significant moderators of abstinence outcomes. These findings support previous hypotheses and replicate findings in clinical trials (e.g., 30) that acamprosate is more effective when administered to patients who are not currently drinking. However, this review is the first to test these study […]